Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients-Reference-Cited by-同舟云学术

Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients

Published:2021-02 Issue: Volume:101 Page:106497
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Marconi Giovanni^ORCID,De Polo Stefano,Martinelli Giovanni,Nanni Jacopo,Bertamini Luca,Talami Annalisa,Olivi Matteo,Ragaini Simone,Abbenante Maria Chiara,Sartor Chiara,Ottaviani Emanuela,Bochicchio Maria Teresa,Parisi Sarah,Fontana Maria Chiara,Cristiano Gianluca,Raffini Maddalena,Baldazzi Carmen,Testoni Nicoletta,Bonifazi Francesca,Paolini Stefania,Curti Antonio,Cavo Michele,Papayannidis Cristina

Funder

ELN

AIL

AIRC

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference31 articles.

1. Genomic structure of the downstream part of the human FLT3 gene: exon/intron structure conservation among genes encoding receptor tyrosine kinases (RTK) of subclass III;Agnès;Gene.,1994

2. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines;Yokota;Leuk. Off. J. Leuk. Soc. Am. Leuk. Res. Fund, U.K.,1997

3. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia;Patel;N. Engl. J. Med.,2012

4. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N. Engl. J. Med.,2016

5. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system;Weinberg;Blood.,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience;Leukemia Research;2024-01

2. Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations;Pharmaceutics;2021-10-02